Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method

Highlights • Robust preparation of liposomal formulation by DELOS-susp method.• Implementation of Quality by Design methodology to liposomes preparation.• Influence of critical parameters on quality was studied through DoE analysis.• Design Space was obtained for GLA-loaded liposomes formulation.

[1]  Ibo van de Poel,et al.  Safe-by-Design: from Safety to Responsibility , 2017, Nanoethics.

[2]  I. Pintre,et al.  Binding and Reactivity at Bilayer Membranes. , 2013 .

[3]  D. Danino.  Cryo-TEM of soft molecular assemblies , 2012 .

[4]  N Grimaldi,et al.  Lipid-based nanovesicles for nanomedicine. , 2016, Chemical Society reviews.

[5]  Franco Dosio,et al.  PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. , 2012, Current drug metabolism.

[6]  G. Husseini,et al.  Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes. , 2020, ACS biomaterials science & engineering.

[7]  F. Albericio,et al.  Synthesis of Stable Cholesteryl–Polyethylene Glycol–Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths , 2020, ACS omega.

[8]  M. Garcia-Parajo,et al.  Highly Versatile Polyelectrolyte Complexes for Improving the Enzyme Replacement Therapy of Lysosomal Storage Disorders. , 2016, ACS applied materials & interfaces.

[9]  D. Danino,et al.  Structure and kinetics of lipid-nucleic acid complexes. , 2014, Advances in colloid and interface science.

[10]  Andreas Falk,et al.  A methodology on how to create a real-life relevant risk profile for a given nanomaterial , 2017 .

[11]  R. Hosemann,et al.  The interference theory of ideal paracrystals , 1952 .

[12]  S. Lee,et al.  Liposomal Drug Product Development and Quality: Current US Experience and Perspective , 2017, The AAPS Journal.

[13]  J. Veciana,et al.  Multifunctional nanovesicle-bioactive conjugates prepared by a one-step scalable method using CO2-expanded solvents. , 2013, Nano letters.

[14]  V. Karunaratne,et al.  Effect of Lipid Composition on In Vitro Release and Skin Deposition of Curcumin Encapsulated Liposomes , 2016 .

[15]  Sh. E. Shaker,et al.  Factors affecting liposomes particle size prepared by ethanol injection method , 2017, Research in pharmaceutical sciences.

[16]  S. Muro,et al.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives , 2017, Advanced drug delivery reviews.

[17]  S. Sivasubramanian,et al.  Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in bresat cancer cells: an improved nanomedicine strategies , 2016, Scientific Reports.

[18]  M. Oztop,et al.  Food grade liposome systems: Effect of solvent, homogenization types and storage conditions on oxidative and physical stability , 2017 .

[19]  J. Veciana,et al.  Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment. , 2021, ACS applied materials & interfaces.

[20]  Eleanor Stride,et al.  Liposome production by microfluidics: potential and limiting factors , 2016, Scientific Reports.

[21]  D. Lamprou,et al.  Influence of cholesterol on liposome stability and on in vitro drug release , 2015, Drug Delivery and Translational Research.

[22]  A. Rastogi,et al.  A Review of Current and Future Treatment Strategies for Fabry Disease : A Model for Treating Lysosomal Storage Diseases , 2015 .

[23]  G Pabst,et al.  Structural information from multilamellar liposomes at full hydration: full q-range fitting with high quality x-ray data. , 2000, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[24]  Antonio P. Costa,et al.  Protein Encapsulation in Unilamellar Liposomes: High Encapsulation Efficiency and A Novel Technique to Assess Lipid-Protein Interaction , 2012, Pharmaceutical Research.

[25]  J. Veciana,et al.  α‐Galactosidase‐A Loaded‐Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration , 2016, Advanced Healthcare Materials.

[26]  R. Purohit,et al.  Social, Environmental and Ethical Impacts of Nanotechnology , 2017 .

[27]  D. Muntean,et al.  A quality by design approach for the development of lyophilized liposomes with simvastatin , 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[28]  Y. Kotsuchibashi,et al.  Towards a Rational Design of Zeolite-Polymer Composite Nanofibers for Efficient Adsorption of Creatinine , 2016 .

[29]  Diane J Burgess,et al.  A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. , 2012, International journal of pharmaceutics.